Bristol-Myers Squibb (BMY) Announces European Commission Approval of Pending Acquisition of Celgene (CELG)
July 29, 2019 10:10 AM
Bristol-Myers Squibb Company (NYSE: BMY) today announced that the European Commission (EC) has granted unconditional approval of Bristol-Myers Squibb’s pending ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
